These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14381226)

  • 21. Mestinon (pyridostigmine bromide) in myasthenia gravis.
    SCHWARZ H
    Can Med Assoc J; 1956 Jul; 75(2):98-100. PubMed ID: 13343058
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies in myasthenia gravis; preliminary report on therapy with mestinon bromide.
    OSSERMAN KE; TENG P; KAPLAN LI
    J Am Med Assoc; 1954 Jul; 155(11):961-5. PubMed ID: 13162833
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of 3-hydroxy phenyl-dimethylethylammonium chloride (tensilon) in myasthenia gravis.
    WESTERBERG MR; MAGEE KR; SHIDEMAN FE
    Med Bull (Ann Arbor); 1951 Sep; 17(9):311-6. PubMed ID: 14893613
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
    SCHWAB RS; OSSERMAN KE; TETHER JE
    J Am Med Assoc; 1957 Oct; 165(6):671-4. PubMed ID: 13462827
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new preparation for symptomatic therapy of myasthenia; dimethylcarbamic ester of l-methyl-3-hydroxypyridine].
    RIGOTTI S; SCHERGNA E
    Gazz Med Ital; 1954 May; 113(5):141-5. PubMed ID: 13191526
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mestinon, a prostigmine homologue, in therapy of myasthenia gravis].
    ENGBAEK L
    Ugeskr Laeger; 1954 Sep; 116(35):1252-4. PubMed ID: 13217054
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new drug for the treatment of myasthenia gravis].
    KOSONEN T
    Duodecim; 1956; 72(12):1033-4. PubMed ID: 13397477
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mysuran, a new preparation for myasthenia gravis].
    OFTEDAL SI
    Nord Med; 1957 May; 57(21):748-9. PubMed ID: 13457385
    [No Abstract]   [Full Text] [Related]  

  • 29. Mestinon in myasthenia gravis; preliminary report.
    TETHER JE
    Dis Nerv Syst; 1954 Aug; 15(8):227-31. PubMed ID: 13191272
    [No Abstract]   [Full Text] [Related]  

  • 30. [Initial experiments with pyridostigmine (mestinon Roche)].
    RADERMECKER MA
    Acta Neurol Psychiatr Belg; 1955 Apr; 55(4):356-63. PubMed ID: 13248495
    [No Abstract]   [Full Text] [Related]  

  • 31. [Case of myasthenia gravis].
    KATILA O; KIVALO E
    Duodecim; 1955; 71(4):605-10. PubMed ID: 14391241
    [No Abstract]   [Full Text] [Related]  

  • 32. [Further progress in therapy of myasthenic syndrome].
    STRUPPLER A
    Med Monatsschr; 1953 Jul; 7(7):428-32. PubMed ID: 13098853
    [No Abstract]   [Full Text] [Related]  

  • 33. Urecholine in myasthenia gravis.
    SCHWARZ H
    Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress report on mestinon bromide (pyridostigmine bromide).
    OSSERMAN KE
    Am J Med; 1955 Nov; 19(5):737-9. PubMed ID: 13268474
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract]   [Full Text] [Related]  

  • 36. [A new drug, pyridostigmine, in therapy of myasthenia].
    FURTADO D
    J Med (Oporto); 1954 Apr; 23(586):953-9. PubMed ID: 13162673
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myasthenia and mediastinal tumor; favorable effect of a new anti-myasthenic preparation].
    SUTTER JM; LARMANDE AM
    Rev Otoneuroophtalmol; 1953; 25(4):231-4. PubMed ID: 13112901
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of myasthenia gravis].
    Szobor A; Klein M
    Psychiatr Neurol Med Psychol (Leipz); 1976 Jan; 28(1):33-42. PubMed ID: 940881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F
    Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
    [No Abstract]   [Full Text] [Related]  

  • 40. Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
    MOORE H
    N Engl J Med; 1955 Dec; 253(24):1075-6. PubMed ID: 13272842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.